Active Ingredient History

  • Now
Cenicriviroc is an experimental drug candidate for the treatment of HIV infection and in combination with Tropifexor for non-alcoholic steatohepatitis. It is being developed by Takeda and Tobira Therapeutics.   Wikipedia

  • SMILES: CCCCOCCOc1ccc(cc1)c2ccc3N(CC(C)C)CCC\C(=C/c3c2)\C(=O)Nc4ccc(cc4)[S@@+]([O-])Cc5cncn5CCC
  • Mol. Mass: 696.96
  • ALogP: 8.74
  • ChEMBL Molecules:
More Chemistry
cenicriviroc | cenicriviroc mesylate | tak 652 | tak-652 | tbr652 | tbr 652 | tbr-652


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue